Internal surgical staplers made headline news in 2019. Reports discussed the little-known US Food and Drug Administration database housing tens of thousands of stapler-related problem reports and covered the agency’s recent proposal to reclassify staplers as Class II devices, instead of the more lightly regulated Class I.
What happens when a surgeon uses the monopolar instrument set…
Stem cell therapy is poised to revolutionize regenerative medicine. As…
Perioperative leaders are entering a time of uncertainty after 2024…